Extended Data Fig. 10: AZD treatment normalizes myocardial Nrf2 signalling pathway in dbCM. | Nature Cardiovascular Research

Extended Data Fig. 10: AZD treatment normalizes myocardial Nrf2 signalling pathway in dbCM.

From: Targeting immunometabolic pathways with AZD1656 alleviates inflammation and metabolic dysfunction in type 2 diabetic cardiomyopathy

Extended Data Fig. 10: AZD treatment normalizes myocardial Nrf2 signalling pathway in dbCM.

Qiagen Ingenuity Pathway Analysis (IPA) based on RNA sequencing results (n = 6/group). IPA utilise hypergeometric test and Benjamini-Hochberg p-value correction to identify all ontology and pathway terms that contain a statistically greater number of genes in common with an input list than expected by chance. n represents biological replicates (individual animals).

Back to article page